Despite the advances of therapeutic approaches, morbidity and mortality rate of oral squamous cell carcinoma (OSCC) have not improved significantly during the last 30 years. Photodynamic therapy (PDT) represents a potential treatment modality for locally recurrent OSCC. However, treatment resistance attributed to PDT-induced epidermal growth factor receptor (EGFR) up-regulation was reported. Here, we showed that vandetanib, a multi-target tyrosine kinase inhibitor that inhibits EGFR and vascular endothelial growth factor receptor-2 (VEGFR-2) enhance the efficacy of PDT. First, we observed increased cytotoxicity in the combinatorial treatment that is attributed to impaired DNA double strand break (DSB) repair. We revealed significant down-regulation DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression to be the downstream target following inhibition of nuclear EGFR accumulation, therefore impairing non-homologous end-joining (NHEJ) following PDT. Next, the combinatorial treatment-mediated tumour vasculature shutdown and normalisation, coupled with reduction of PDT-induced EGFR activation corresponded to the most pronounced tumour growth delay in vivo. Interestingly, we observed the restoration of tumour cell proliferation and vascularisation, coupled with ERK1/2 activation in the recurrent tumours post-vandetanib+PDT treatment. This corroborated the importance of the modulation of the tumour microenvironment for the observed synergistic efficacy of vandetanib+PDT combinatorial treatment. Collectively, our data suggests that vandetanib works synergistically with PDT through the impairment of EGFR-dependent DNA repair machinery and modulation of tumour microenvironment.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.